Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation? - KIVIRID

Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?

Authors: Ameet Sarpatwari, Jerry Avorn, Aaron S Kesselheim

Published: 2020-10-08

DOI: 10.1136/bmj.m3841

Source: Full article

Abstract

No abstract found.